Korro Bio (KRRO) Competitors $12.90 -0.19 (-1.45%) As of 03:01 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock KRRO vs. ATYR, KMDA, ATAI, TRML, MREO, RGNX, PGEN, RAPP, ORKA, and PRTCShould you be buying Korro Bio stock or one of its competitors? The main competitors of Korro Bio include aTyr Pharma (ATYR), Kamada (KMDA), atai Life Sciences (ATAI), Tourmaline Bio (TRML), Mereo BioPharma Group (MREO), REGENXBIO (RGNX), Precigen (PGEN), Rapport Therapeutics (RAPP), Oruka Therapeutics (ORKA), and PureTech Health (PRTC). These companies are all part of the "pharmaceutical products" industry. Korro Bio vs. Its Competitors aTyr Pharma Kamada atai Life Sciences Tourmaline Bio Mereo BioPharma Group REGENXBIO Precigen Rapport Therapeutics Oruka Therapeutics PureTech Health Korro Bio (NASDAQ:KRRO) and aTyr Pharma (NASDAQ:ATYR) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, valuation, earnings, analyst recommendations, media sentiment, profitability, institutional ownership and risk. Does the media prefer KRRO or ATYR? In the previous week, aTyr Pharma had 1 more articles in the media than Korro Bio. MarketBeat recorded 3 mentions for aTyr Pharma and 2 mentions for Korro Bio. Korro Bio's average media sentiment score of 0.83 beat aTyr Pharma's score of 0.66 indicating that Korro Bio is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Korro Bio 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive aTyr Pharma 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more volatility and risk, KRRO or ATYR? Korro Bio has a beta of 2.43, meaning that its share price is 143% more volatile than the S&P 500. Comparatively, aTyr Pharma has a beta of 0.89, meaning that its share price is 11% less volatile than the S&P 500. Which has preferable valuation & earnings, KRRO or ATYR? aTyr Pharma has lower revenue, but higher earnings than Korro Bio. aTyr Pharma is trading at a lower price-to-earnings ratio than Korro Bio, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioKorro Bio$2.27M53.36-$83.58M-$9.44-1.37aTyr Pharma$230K2,033.07-$64.02M-$0.81-6.49 Do analysts prefer KRRO or ATYR? Korro Bio currently has a consensus target price of $102.43, indicating a potential upside of 694.02%. aTyr Pharma has a consensus target price of $20.20, indicating a potential upside of 284.47%. Given Korro Bio's stronger consensus rating and higher probable upside, analysts plainly believe Korro Bio is more favorable than aTyr Pharma.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Korro Bio 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 2 Strong Buy rating(s) 3.29aTyr Pharma 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 1 Strong Buy rating(s) 3.14 Is KRRO or ATYR more profitable? Korro Bio's return on equity of -51.64% beat aTyr Pharma's return on equity.Company Net Margins Return on Equity Return on Assets Korro BioN/A -51.64% -37.94% aTyr Pharma N/A -87.09%-64.77% Do institutionals & insiders have more ownership in KRRO or ATYR? 13.2% of Korro Bio shares are held by institutional investors. Comparatively, 61.7% of aTyr Pharma shares are held by institutional investors. 4.6% of Korro Bio shares are held by company insiders. Comparatively, 3.7% of aTyr Pharma shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. SummaryKorro Bio beats aTyr Pharma on 10 of the 16 factors compared between the two stocks. Get Korro Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for KRRO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding KRRO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart KRRO vs. The Competition Export to ExcelMetricKorro BioMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$121.13M$2.41B$5.48B$9.01BDividend YieldN/A1.77%5.39%4.10%P/E Ratio-1.378.9827.4320.06Price / Sales53.36468.84398.47108.02Price / CashN/A151.5836.1356.90Price / Book0.754.638.085.67Net Income-$83.58M$31.34M$3.16B$248.47M7 Day Performance4.54%0.84%2.12%2.90%1 Month Performance8.13%7.92%4.43%5.75%1 Year Performance-66.34%1.87%35.62%21.36% Korro Bio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)KRROKorro Bio2.5572 of 5 stars$12.90-1.5%$102.43+694.0%-60.5%$121.13M$2.27M-1.3770ATYRaTyr Pharma2.9858 of 5 stars$5.07+0.8%$20.20+298.4%N/A$447.69M$230K-6.2653Gap UpHigh Trading VolumeKMDAKamada4.1674 of 5 stars$7.75+0.5%$14.67+89.2%+54.8%$443.36M$160.95M26.72360Positive NewsATAIatai Life Sciences3.1394 of 5 stars$2.19-0.5%$8.67+295.7%+111.5%$440.74M$310K-2.4180News CoverageAnalyst ForecastOptions VolumeTRMLTourmaline Bio2.1447 of 5 stars$15.99-3.3%$49.33+208.5%+29.0%$424.84MN/A-4.9844MREOMereo BioPharma Group1.9449 of 5 stars$2.71+1.9%$7.60+180.4%-16.8%$422.94M$10M-38.7140RGNXREGENXBIO4.415 of 5 stars$8.21-2.1%$31.63+285.2%-19.8%$420.85M$83.33M-2.64370PGENPrecigen3.7317 of 5 stars$1.42flat$6.00+322.5%+8.1%$419.16M$3.92M-2.54190News CoverageRAPPRapport Therapeutics1.9466 of 5 stars$11.37-0.5%$32.67+187.3%-52.8%$417.17MN/A-3.30N/ANews CoverageGap UpORKAOruka Therapeutics2.219 of 5 stars$11.21+1.2%$40.38+260.2%N/A$414.84MN/A-2.49N/APRTCPureTech Health2.6077 of 5 stars$17.25+0.6%$45.00+160.9%-27.6%$411.92M$4.83M0.00100Gap Up Related Companies and Tools Related Companies aTyr Pharma Alternatives Kamada Alternatives atai Life Sciences Alternatives Tourmaline Bio Alternatives Mereo BioPharma Group Alternatives REGENXBIO Alternatives Precigen Alternatives Rapport Therapeutics Alternatives Oruka Therapeutics Alternatives PureTech Health Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:KRRO) was last updated on 7/3/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredA grave, grave error.Famed financial analyst, Porter Stansberry, calls this technology “The Final Frontier” because it holds the ke...Porter & Company | SponsoredThis Crypto Is Set to Explode in JanuaryFree summit: How to profit from the Coinbase-Deribit deal Our hedge fund experts know exactly what this mea...Crypto 101 Media | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredForget Nvidia, This “Ghost Town” Company Holds the Key to the AI BoomCold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Korro Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Korro Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.